Color me bad: microbial pigments as virulence factors.

A hallmark feature of several pathogenic microbes is the distinctive color of their colonies when propagated in the clinical laboratory. Such pigmentation comes in a variety of hues, and has often proven useful in presumptive clinical diagnosis. Recent advances in microbial pigment biochemistry and the genetic basis of pigment production have sometimes revealed a more sinister aspect to these curious materials that change the color of reflected light by selective light absorbance. In many cases, the microbial pigment contributes to disease pathogenesis by interfering with host immune clearance mechanisms or by exhibiting pro-inflammatory or cytotoxic properties. We review several examples of pigments that promote microbial virulence, including the golden staphyloxanthin of Staphylococcusaureus, the blue-green pyocyanin of Pseudomonas spp., and the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp. Targeted pigment neutralisation might represent a viable concept to enhance treatment of certain difficult infectious disease conditions.

[1]  S. Kjelleberg,et al.  Impact of Violacein-Producing Bacteria on Survival and Feeding of Bacterivorous Nanoflagellates , 2004, Applied and Environmental Microbiology.

[2]  C. Schmidt-Dannert,et al.  Engineering novel carotenoids in microorganisms. , 2000, Current opinion in biotechnology.

[3]  T. G. Truscott,et al.  Carotenoid radical chemistry and antioxidant/pro-oxidant properties. , 2004, Archives of biochemistry and biophysics.

[4]  E. Jacobson,et al.  Ferric iron reduction by Cryptococcus neoformans , 1997, Infection and immunity.

[5]  B. Monks,et al.  Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.

[6]  J. Nosanchuk,et al.  Melanin and fungi , 2003, Current opinion in infectious diseases.

[7]  A. Casadevall,et al.  Cryptococcus neoformans Can Utilize the Bacterial Melanin Precursor Homogentisic Acid for Fungal Melanogenesis , 2006, Applied and Environmental Microbiology.

[8]  S. Jackson,et al.  A Melanin Pigment Purified from an Epidemic Strain of Burkholderia cepacia Attenuates Monocyte Respiratory Burst Activity by Scavenging Superoxide Anion , 1999, Infection and Immunity.

[9]  D. Hassett,et al.  The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.

[10]  K. Poralla,et al.  Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus , 1994, Journal of bacteriology.

[11]  D. Spitz,et al.  Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[12]  D. Hassett,et al.  Human targets of Pseudomonas aeruginosa pyocyanin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Garger,et al.  Synthetic melanin suppresses production of proinflammatory cytokines. , 2000, Cellular immunology.

[14]  S. Baron,et al.  Antibiotic action of pyocyanin , 1981, Antimicrobial Agents and Chemotherapy.

[15]  C. Rausch,et al.  Microevolution of Cytochrome bd Oxidase in Staphylococci and Its Implication in Resistance to Respiratory Toxins Released by Pseudomonas , 2006, Journal of Bacteriology.

[16]  J. M. Cuerva,et al.  Granadaene: Proposed Structure of the Group B Streptococcus Polyenic Pigment , 2006, Applied and Environmental Microbiology.

[17]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[18]  A. Kourounakis,et al.  Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease. , 1998, Arzneimittel-Forschung.

[19]  G. Denning,et al.  Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[20]  S. Gribaldo,et al.  Study of a melanic pigment of Proteus mirabilis. , 1996, Research in microbiology.

[21]  T. Egan,et al.  Haemozoin formation. , 2008, Molecular and biochemical parasitology.

[22]  V. Nizet,et al.  Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  V. Nizet,et al.  A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. , 2008, Science.

[24]  H. Forman,et al.  Redox signaling in macrophages. , 2001, Molecular aspects of medicine.

[25]  M. Wheeler,et al.  Biosynthesis and Functions of Melanin inSporothrix schenckii , 2000, Infection and Immunity.

[26]  S. Bhakdi,et al.  Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence , 1997, Infection and immunity.

[27]  D. Hassett,et al.  Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vaculoar ATPase‐dependent cystic fibrosis transmembrane conductance regulator expression and localization , 2006, Cellular microbiology.

[28]  A. Carvalho,et al.  [Chronic granulomatous disease]. , 1973, AMB : revista da Associacao Medica Brasileira.

[29]  J. Smalley,et al.  The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the mu-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. , 1998, The Biochemical journal.

[30]  J. Curtis,et al.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. , 1995, Journal of immunology.

[31]  A. Casadevall,et al.  Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin , 2002, Antimicrobial Agents and Chemotherapy.

[32]  V. Choubey,et al.  Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. , 2007, Life sciences.

[33]  C. Nathan Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. , 2003, The Journal of clinical investigation.

[34]  A. Casadevall,et al.  Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection , 2001, Infection and Immunity.

[35]  N. Durán,et al.  Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. , 2006, Carcinogenesis.

[36]  D. Hassett,et al.  Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.

[37]  K. Tracey,et al.  Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. , 1995, Journal of inflammation.

[38]  V. Soto-Cerrato,et al.  The prodigiosins, proapoptotic drugs with anticancer properties. , 2003, Biochemical pharmacology.

[39]  V. Choubey,et al.  Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic update , 2007 .

[40]  R. Tompkins,et al.  The Drosophila melanogaster Toll Pathway Participates in Resistance to Infection by the Gram-Negative Human Pathogen Pseudomonas aeruginosa , 2003, Infection and Immunity.

[41]  B. Moore,et al.  Exploiting marine actinomycete biosynthetic pathways for drug discovery , 2004, Antonie van Leeuwenhoek.

[42]  A. Casadevall,et al.  The antibody response to fungal melanin in mice. , 1998, Journal of immunology.

[43]  G. Denning,et al.  The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[44]  B. Spellerberg,et al.  The cyl genes of Streptococcus agalactiae are involved in the production of pigment. , 2000, FEMS microbiology letters.

[45]  A. Casadevall,et al.  Melanization of Cryptococcus neoformans Affects Lung Inflammatory Responses during Cryptococcal Infection , 2005, Infection and Immunity.

[46]  G. Taylor,et al.  Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium , 1988, Infection and immunity.

[47]  D. Look,et al.  Pyocyanin and Its Precursor Phenazine-1-Carboxylic Acid Increase IL-8 and Intercellular Adhesion Molecule-1 Expression in Human Airway Epithelial Cells by Oxidant-Dependent Mechanisms1 , 2005, The Journal of Immunology.

[48]  B. Commoner,et al.  Free Radicals in Biological Materials , 1954, Nature.

[49]  P. Arese,et al.  Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes , 1998, Infection and Immunity.

[50]  L. Stoll,et al.  Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells , 1998, Infection and Immunity.

[51]  C. Coban,et al.  Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.

[52]  Frederick M. Ausubel,et al.  Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas Aeruginosa– Caenorhabditis Elegans Pathogenesis Model , 2022 .

[53]  R. Wilson,et al.  Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro , 1993, Infection and immunity.

[54]  H. Ginsburg,et al.  Impairment of Macrophage Functions after Ingestion of Plasmodium s Erythrocytes or Isolated Malarial Pigment , 2003 .

[55]  G. Taylor,et al.  Induction of Neutrophil Apoptosis by the Pseudomonas aeruginosa Exotoxin Pyocyanin: A Potential Mechanism of Persistent Infection1 , 2002, The Journal of Immunology.

[56]  J. Smalley,et al.  The haem pigment of the oral anaerobes Prevotella nigrescens and Prevotella intermedia is composed of iron(III) protoporphyrin IX in the monomeric form. , 2003, Microbiology.

[57]  Y. Jeon,et al.  Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis. , 2001, The Journal of pharmacology and experimental therapeutics.

[58]  D. Bryant,et al.  Chlorophyll biosynthesis in bacteria: the origins of structural and functional diversity. , 2007, Annual review of microbiology.

[59]  V. Nizet Streptococcal β-hemolysins: genetics and role in disease pathogenesis , 2002 .

[60]  T. Vieira,et al.  Antioxidant properties of violacein: possible relation on its biological function. , 2006, Bioorganic & medicinal chemistry.

[61]  A. Casadevall,et al.  Effects of disrupting the polyketide synthase gene WdPKS1 in Wangiella [Exophiala] dermatitidis on melanin production and resistance to killing by antifungal compounds, enzymatic degradation, and extremes in temperature , 2006, BMC Microbiology.

[62]  Nelson Durán,et al.  Molecular mechanism of violacein-mediated human leukemia cell death. , 2004, Blood.

[63]  M. Hauser,et al.  Molecular Cloning and Characterization ofWdPKS1, a Gene Involved in Dihydroxynaphthalene Melanin Biosynthesis and Virulence in Wangiella(Exophiala) dermatitidis , 2001, Infection and Immunity.

[64]  V. Nizet,et al.  Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity , 2005, The Journal of experimental medicine.

[65]  N. Cianciotto,et al.  The Secreted Pyomelanin Pigment of Legionella pneumophila Confers Ferric Reductase Activity , 2007, Infection and Immunity.

[66]  E. Jacobson Pathogenic roles for fungal melanins. , 2000, Clinical microbiology reviews.

[67]  J. Tapsall Pigment production by Lancefield-group-B streptococci (Streptococcus agalactiae). , 1986, Journal of medical microbiology.

[68]  Nicholas J. Jacobs,et al.  Characterization and incidence of pigment production by human clinical group B streptococci , 1978, Journal of clinical microbiology.

[69]  N Durán,et al.  Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. , 2001, The Journal of antimicrobial chemotherapy.

[70]  K. Kwon-Chung,et al.  The Developmentally Regulated alb1 Gene ofAspergillus fumigatus: Its Role in Modulation of Conidial Morphology and Virulence , 1998, Journal of bacteriology.

[71]  F. Bistoni,et al.  Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain , 2000, Journal of Neuroimmunology.

[72]  F. Götz,et al.  Structure and Biosynthesis of Staphyloxanthin from Staphylococcus aureus* , 2005, Journal of Biological Chemistry.

[73]  A. Peschel,et al.  Staphyloxanthin Plays a Role in the Fitness of Staphylococcus aureus and Its Ability To Cope with Oxidative Stress , 2006, Infection and Immunity.

[74]  M. Danilenko,et al.  Carotenoids and transcription. , 2004, Archives of biochemistry and biophysics.

[75]  Daniel G. Lee,et al.  Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo1 , 2005, The Journal of Immunology.

[76]  A. Casadevall,et al.  Impact of Melanin on Microbial Virulence and Clinical Resistance to Antimicrobial Compounds , 2006, Antimicrobial Agents and Chemotherapy.

[77]  N Durán,et al.  Chromobacterium violaceum: A Review of Pharmacological and Industiral Perspectives , 2001, Critical reviews in microbiology.

[78]  D. Sullivan Theories on malarial pigment formation and quinoline action. , 2002, International journal for parasitology.

[79]  W. K. Roberts,et al.  Melanin as a potential cryptococcal defence against microbicidal proteins. , 1999, Medical mycology.

[80]  I. Polacheck,et al.  Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice , 1982, Journal of bacteriology.

[81]  A. Casadevall,et al.  Virulence: Mechanism of Action. Cryptococcus Neoformans Melanin And , 1995 .

[82]  P. J. Szaniszlo,et al.  Melanized and non‐melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies , 1992, Mycoses.

[83]  J. Marshall,et al.  Cytotoxic effects of violacein in human uveal melanoma cell lines , 2004, Melanoma research.

[84]  O. Skorokhod,et al.  Hemozoin (Malarial Pigment) Inhibits Differentiation and Maturation of Human Monocyte-Derived Dendritic Cells: A Peroxisome Proliferator-Activated Receptor-γ-Mediated Effect1 , 2004, The Journal of Immunology.

[85]  J. Perfect,et al.  Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans , 1996, The Journal of experimental medicine.

[86]  K. Kwon-Chung,et al.  Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition , 1997, Molecular microbiology.

[87]  A. Casadevall,et al.  Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. , 2001, The Journal of infectious diseases.

[88]  Finian J. Leeper,et al.  The biosynthesis and regulation of bacterial prodiginines , 2006, Nature Reviews Microbiology.

[89]  W. Merz,et al.  Two rapid pigmentation tests for identification of Cryptococcus neoformans , 1982, Journal of clinical microbiology.

[90]  Christopher T Walsh,et al.  In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA-E from Chromobacterium violaceum. , 2006, Biochemistry.